DK2501805T3 - Yeast strains producing mammalian-like complex N-Glycans - Google Patents

Info

Publication number

DK2501805T3

DK2501805T3 DK10812879.4T DK10812879T DK2501805T3 DK 2501805 T3 DK2501805 T3 DK 2501805T3 DK 10812879 T DK10812879 T DK 10812879T DK 2501805 T3 DK2501805 T3 DK 2501805T3

Authority

DK

Denmark

Prior art keywords

nucleic acid

glycans

cell

acid encoding

transferase

Prior art date

2009-11-19

Links

• Espacenet
• Global Dossier
• Discuss

• 240000004808 Saccharomyces cerevisiae Species 0.000 title description 26
• 108090000623 proteins and genes Proteins 0.000 claims description 330
• 210000004027 cell Anatomy 0.000 claims description 302
• 102000004169 proteins and genes Human genes 0.000 claims description 260
• 150000007523 nucleic acids Chemical class 0.000 claims description 218
• 102000039446 nucleic acids Human genes 0.000 claims description 213
• 108020004707 nucleic acids Proteins 0.000 claims description 213
• 230000014509 gene expression Effects 0.000 claims description 138
• 230000000694 effects Effects 0.000 claims description 102
• 238000000034 method Methods 0.000 claims description 96
• 230000008685 targeting Effects 0.000 claims description 86
• 241000235015 Yarrowia lipolytica Species 0.000 claims description 82
• 108060003306 Galactosyltransferase Proteins 0.000 claims description 69
• 102000030902 Galactosyltransferase Human genes 0.000 claims description 69
• 239000002773 nucleotide Substances 0.000 claims description 56
• 125000003729 nucleotide group Chemical group 0.000 claims description 56
• 108010029607 4-nitrophenyl-alpha-glucosidase Proteins 0.000 claims description 46
• 239000012634 fragment Substances 0.000 claims description 37
• 102000004357 Transferases Human genes 0.000 claims description 36
• 108090000992 Transferases Proteins 0.000 claims description 36
• 230000002950 deficient Effects 0.000 claims description 34
• 230000003834 intracellular effect Effects 0.000 claims description 29
• 230000003197 catalytic effect Effects 0.000 claims description 27
• 102000003886 Glycoproteins Human genes 0.000 claims description 26
• 108090000288 Glycoproteins Proteins 0.000 claims description 26
• 101150061302 och1 gene Proteins 0.000 claims description 26
• 241000235013 Yarrowia Species 0.000 claims description 22
• 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 22
• 210000002288 golgi apparatus Anatomy 0.000 claims description 22
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
• 102100032086 Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 claims description 17
• 101000776319 Homo sapiens Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 claims description 17
• 230000004927 fusion Effects 0.000 claims description 14
• 230000001225 therapeutic effect Effects 0.000 claims description 14
• 102000003951 Erythropoietin Human genes 0.000 claims description 9
• 108090000394 Erythropoietin Proteins 0.000 claims description 9
• 229940105423 erythropoietin Drugs 0.000 claims description 9
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 9
• 102000009109 Fc receptors Human genes 0.000 claims description 8
• 108010087819 Fc receptors Proteins 0.000 claims description 8
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 8
• 238000012546 transfer Methods 0.000 claims description 8
• 108010022308 beta-1,4-galactosyltransferase I Proteins 0.000 claims description 6
• 230000008569 process Effects 0.000 claims description 5
• 102000008070 Interferon-gamma Human genes 0.000 claims description 3
• 108010074328 Interferon-gamma Proteins 0.000 claims description 3
• 229960003130 interferon gamma Drugs 0.000 claims description 3
• 102100021771 Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase Human genes 0.000 claims 12
• 108010009689 mannosyl-oligosaccharide 1,2-alpha-mannosidase Proteins 0.000 claims 12
• 102100039059 Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Human genes 0.000 claims 4
• 101000958975 Homo sapiens Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Proteins 0.000 claims 4
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
• 210000003093 intracellular space Anatomy 0.000 claims 1
• 235000018102 proteins Nutrition 0.000 description 145
• 230000002538 fungal effect Effects 0.000 description 59
• 239000013612 plasmid Substances 0.000 description 49
• 230000004988 N-glycosylation Effects 0.000 description 46
• 239000013598 vector Substances 0.000 description 45
• 230000010354 integration Effects 0.000 description 41
• 238000011282 treatment Methods 0.000 description 41
• WYUKJASPBYYQRJ-VSJOFRJTSA-N beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 WYUKJASPBYYQRJ-VSJOFRJTSA-N 0.000 description 40
• 108020004414 DNA Proteins 0.000 description 38
• 108020001507 fusion proteins Proteins 0.000 description 38
• 102000037865 fusion proteins Human genes 0.000 description 38
• 238000004458 analytical method Methods 0.000 description 33
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
• ZTOKCBJDEGPICW-GWPISINRSA-N alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)[C@@H](CO)O1 ZTOKCBJDEGPICW-GWPISINRSA-N 0.000 description 30
• 108010083819 mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase Proteins 0.000 description 30
• ZTOKCBJDEGPICW-UHFFFAOYSA-N Man3GlcNAc2 Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(NC(C)=O)C(O)C(OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(COC3C(C(O)C(O)C(CO)O3)O)O2)O)C(CO)O1 ZTOKCBJDEGPICW-UHFFFAOYSA-N 0.000 description 29
• 241000282414 Homo sapiens Species 0.000 description 25
• 206010028980 Neoplasm Diseases 0.000 description 25
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 24
• GRHWEVYJIHXESA-HBHDJDHDSA-N beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 GRHWEVYJIHXESA-HBHDJDHDSA-N 0.000 description 24
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
• 208000030159 metabolic disease Diseases 0.000 description 24
• 238000010276 construction Methods 0.000 description 22
• 201000011510 cancer Diseases 0.000 description 21
• 239000008194 pharmaceutical composition Substances 0.000 description 19
• 244000288561 Torulaspora delbrueckii Species 0.000 description 18
• 230000009466 transformation Effects 0.000 description 18
• 102000004190 Enzymes Human genes 0.000 description 17
• 108090000790 Enzymes Proteins 0.000 description 17
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 17
• 208000035475 disorder Diseases 0.000 description 17
• 229940088598 enzyme Drugs 0.000 description 17
• 108010054377 Mannosidases Proteins 0.000 description 15
• 102000001696 Mannosidases Human genes 0.000 description 15
• 208000027866 inflammatory disease Diseases 0.000 description 15
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 14
• 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 14
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 14
• 238000006243 chemical reaction Methods 0.000 description 14
• 241000894007 species Species 0.000 description 14
• 208000024891 symptom Diseases 0.000 description 14
• 108020004705 Codon Proteins 0.000 description 13
• 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 13
• 101150001810 TEAD1 gene Proteins 0.000 description 13
• 101150074253 TEF1 gene Proteins 0.000 description 13
• 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 13
• 101150050575 URA3 gene Proteins 0.000 description 13
• -1 cerebrosidase Proteins 0.000 description 13
• 239000003550 marker Substances 0.000 description 13
• 241000235648 Pichia Species 0.000 description 12
• 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 12
• 150000001413 amino acids Chemical group 0.000 description 12
• 238000000338 in vitro Methods 0.000 description 12
• 230000001939 inductive effect Effects 0.000 description 12
• 210000005253 yeast cell Anatomy 0.000 description 12
• 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 11
• 230000013595 glycosylation Effects 0.000 description 11
• 238000006206 glycosylation reaction Methods 0.000 description 11
• 201000002200 Congenital disorder of glycosylation Diseases 0.000 description 10
• 239000003795 chemical substances by application Substances 0.000 description 10
• 238000000855 fermentation Methods 0.000 description 10
• 230000004151 fermentation Effects 0.000 description 10
• 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 10
• 230000002018 overexpression Effects 0.000 description 10
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 10
• 230000001105 regulatory effect Effects 0.000 description 10
• 241000235070 Saccharomyces Species 0.000 description 9
• 230000008859 change Effects 0.000 description 9
• 239000013604 expression vector Substances 0.000 description 9
• 239000000203 mixture Substances 0.000 description 9
• 102000002268 Hexosaminidases Human genes 0.000 description 8
• 108010000540 Hexosaminidases Proteins 0.000 description 8
• 208000015439 Lysosomal storage disease Diseases 0.000 description 8
• 238000002105 Southern blotting Methods 0.000 description 8
• 239000000427 antigen Substances 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 230000009977 dual effect Effects 0.000 description 8
• 238000010353 genetic engineering Methods 0.000 description 8
• 230000012010 growth Effects 0.000 description 8
• 238000004519 manufacturing process Methods 0.000 description 8
• HNQXDLYBFNWFEE-VHZSLYHRSA-N n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-5-[(2r,3s,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-1-oxo-4-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] Chemical compound O([C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1[C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O HNQXDLYBFNWFEE-VHZSLYHRSA-N 0.000 description 8
• 241000228245 Aspergillus niger Species 0.000 description 7
• 241000680806 Blastobotrys adeninivorans Species 0.000 description 7
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 7
• 241000235062 Pichia membranifaciens Species 0.000 description 7
• 108091007433 antigens Proteins 0.000 description 7
• 102000036639 antigens Human genes 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 235000001727 glucose Nutrition 0.000 description 7
• 230000035772 mutation Effects 0.000 description 7
• 239000000126 substance Substances 0.000 description 7
• 229940035893 uracil Drugs 0.000 description 7
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
• 108091026890 Coding region Proteins 0.000 description 6
• 108010051219 Cre recombinase Proteins 0.000 description 6
• 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 6
• 101710121417 Envelope glycoprotein Proteins 0.000 description 6
• 101100058003 Yarrowia lipolytica (strain CLIB 122 / E 150) AXP1 gene Proteins 0.000 description 6
• 230000001580 bacterial effect Effects 0.000 description 6
• 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 6
• 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• 150000001875 compounds Chemical class 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 108090000765 processed proteins & peptides Proteins 0.000 description 6
• 239000000523 sample Substances 0.000 description 6
• 230000009962 secretion pathway Effects 0.000 description 6
• 238000003860 storage Methods 0.000 description 6
• INOZZBHURUDQQR-AJNGGQMLSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 INOZZBHURUDQQR-AJNGGQMLSA-N 0.000 description 5
• 229930024421 Adenine Natural products 0.000 description 5
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 5
• 102000014150 Interferons Human genes 0.000 description 5
• 108010050904 Interferons Proteins 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 206010027476 Metastases Diseases 0.000 description 5
• 208000002193 Pain Diseases 0.000 description 5
• 241000235072 Saccharomyces bayanus Species 0.000 description 5
• 108700005078 Synthetic Genes Proteins 0.000 description 5
• 241000499912 Trichoderma reesei Species 0.000 description 5
• 241000700605 Viruses Species 0.000 description 5
• 241000235017 Zygosaccharomyces Species 0.000 description 5
• 241000235033 Zygosaccharomyces rouxii Species 0.000 description 5
• 229960000643 adenine Drugs 0.000 description 5
• 210000004102 animal cell Anatomy 0.000 description 5
• 230000037396 body weight Effects 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 238000010586 diagram Methods 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 108010041601 histidyl-aspartyl-glutamyl-leucine Proteins 0.000 description 5
• 230000006801 homologous recombination Effects 0.000 description 5
• 238000002744 homologous recombination Methods 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 230000037361 pathway Effects 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 239000004055 small Interfering RNA Substances 0.000 description 5
• 238000003786 synthesis reaction Methods 0.000 description 5
• 230000002194 synthesizing effect Effects 0.000 description 5
• 231100000331 toxic Toxicity 0.000 description 5
• 230000002588 toxic effect Effects 0.000 description 5
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
• 206010011224 Cough Diseases 0.000 description 4
• 241000701022 Cytomegalovirus Species 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• 230000025545 Golgi localization Effects 0.000 description 4
• 241000235058 Komagataella pastoris Species 0.000 description 4
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 4
• 241000235034 Zygosaccharomyces bisporus Species 0.000 description 4
• 229910052799 carbon Inorganic materials 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 230000007812 deficiency Effects 0.000 description 4
• 239000008103 glucose Substances 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 229940079322 interferon Drugs 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 229920001184 polypeptide Polymers 0.000 description 4
• 102000004196 processed proteins & peptides Human genes 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 235000000346 sugar Nutrition 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 206010000060 Abdominal distension Diseases 0.000 description 3
• 241000219194 Arabidopsis Species 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 102100027321 Beta-1,4-galactosyltransferase 7 Human genes 0.000 description 3
• 206010010904 Convulsion Diseases 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 3
• 241000588724 Escherichia coli Species 0.000 description 3
• 208000024720 Fabry Disease Diseases 0.000 description 3
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 3
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 241001661345 Moesziomyces antarcticus Species 0.000 description 3
• 101000946797 Mus musculus C-C motif chemokine 9 Proteins 0.000 description 3
• 108010025020 Nerve Growth Factor Proteins 0.000 description 3
• 206010037660 Pyrexia Diseases 0.000 description 3
• 241000221523 Rhodotorula toruloides Species 0.000 description 3
• 108020004459 Small interfering RNA Proteins 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 description 3
• HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 3
• 108010063641 Xylosylprotein 4-beta-galactosyltransferase Proteins 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 230000007815 allergy Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 108010005774 beta-Galactosidase Proteins 0.000 description 3
• 229960000074 biopharmaceutical Drugs 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 238000012364 cultivation method Methods 0.000 description 3
• 238000012258 culturing Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 238000001962 electrophoresis Methods 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 206010016256 fatigue Diseases 0.000 description 3
• 238000012239 gene modification Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 230000005017 genetic modification Effects 0.000 description 3
• 235000013617 genetically modified food Nutrition 0.000 description 3
• 150000002304 glucoses Chemical class 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 239000000543 intermediate Substances 0.000 description 3
• 108091070501 miRNA Proteins 0.000 description 3
• 239000002679 microRNA Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 238000003032 molecular docking Methods 0.000 description 3
• 201000006417 multiple sclerosis Diseases 0.000 description 3
• 201000006938 muscular dystrophy Diseases 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 238000006722 reduction reaction Methods 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 150000008163 sugars Chemical class 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 230000010474 transient expression Effects 0.000 description 3
• 239000006163 transport media Substances 0.000 description 3
• 230000001960 triggered effect Effects 0.000 description 3
• 238000009966 trimming Methods 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• 238000001262 western blot Methods 0.000 description 3
• OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 108020005296 Acid Ceramidase Proteins 0.000 description 2
• 102000006772 Acid Ceramidase Human genes 0.000 description 2
• HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
• 208000000230 African Trypanosomiasis Diseases 0.000 description 2
• 101150039297 Alg3 gene Proteins 0.000 description 2
• 102100022146 Arylsulfatase A Human genes 0.000 description 2
• 102100031491 Arylsulfatase B Human genes 0.000 description 2
• 108010023546 Aspartylglucosylaminase Proteins 0.000 description 2
• 241000228212 Aspergillus Species 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 241001489226 Barnettozyma californica Species 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 2
• 102100023700 C-C motif chemokine 16 Human genes 0.000 description 2
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
• 108090000625 Cathepsin K Proteins 0.000 description 2
• 102000004171 Cathepsin K Human genes 0.000 description 2
• 108010036867 Cerebroside-Sulfatase Proteins 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 208000029448 Chylomicron retention disease Diseases 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 2
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
• 241000255601 Drosophila melanogaster Species 0.000 description 2
• 208000000059 Dyspnea Diseases 0.000 description 2
• 206010013975 Dyspnoeas Diseases 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 108010093031 Galactosidases Proteins 0.000 description 2
• 102000002464 Galactosidases Human genes 0.000 description 2
• 102100024637 Galectin-10 Human genes 0.000 description 2
• 208000015872 Gaucher disease Diseases 0.000 description 2
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102000004858 Growth differentiation factor-9 Human genes 0.000 description 2
• 108090001086 Growth differentiation factor-9 Proteins 0.000 description 2
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 2
• 208000006933 Hermanski-Pudlak Syndrome Diseases 0.000 description 2
• 206010071775 Hermansky-Pudlak syndrome Diseases 0.000 description 2
• 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 2
• 101100084403 Homo sapiens PRODH gene Proteins 0.000 description 2
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000701806 Human papillomavirus Species 0.000 description 2
• 108010003272 Hyaluronate lyase Proteins 0.000 description 2
• 102000001974 Hyaluronidases Human genes 0.000 description 2
• 102100029199 Iduronate 2-sulfatase Human genes 0.000 description 2
• 101710096421 Iduronate 2-sulfatase Proteins 0.000 description 2
• 108010003381 Iduronidase Proteins 0.000 description 2
• 102000004627 Iduronidase Human genes 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000014429 Insulin-like growth factor Human genes 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 241001661539 Kregervanrija fluxuum Species 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 102000004882 Lipase Human genes 0.000 description 2
• 108090001060 Lipase Proteins 0.000 description 2
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 2
• 102100022119 Lipoprotein lipase Human genes 0.000 description 2
• 206010027452 Metastases to bone Diseases 0.000 description 2
• 206010027457 Metastases to liver Diseases 0.000 description 2
• 206010027458 Metastases to lung Diseases 0.000 description 2
• 241000235042 Millerozyma farinosa Species 0.000 description 2
• 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 2
• 208000008955 Mucolipidoses Diseases 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 206010052904 Musculoskeletal stiffness Diseases 0.000 description 2
• 108010056852 Myostatin Proteins 0.000 description 2
• 102100021003 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Human genes 0.000 description 2
• 108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 description 2
• 206010028813 Nausea Diseases 0.000 description 2
• 102000015336 Nerve Growth Factor Human genes 0.000 description 2
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 2
• 238000010222 PCR analysis Methods 0.000 description 2
• 101150059359 POX2 gene Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 241000521553 Pichia fermentans Species 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 241001136637 Priceomyces carsonii Species 0.000 description 2
• 102100028772 Proline dehydrogenase 1, mitochondrial Human genes 0.000 description 2
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
• 102100038358 Prostate-specific antigen Human genes 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 102000004879 Racemases and epimerases Human genes 0.000 description 2
• 108090001066 Racemases and epimerases Proteins 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 241000223253 Rhodotorula glutinis Species 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 241000877399 Saccharomyces chevalieri Species 0.000 description 2
• 244000253911 Saccharomyces fragilis Species 0.000 description 2
• 235000018368 Saccharomyces fragilis Nutrition 0.000 description 2
• 241000582914 Saccharomyces uvarum Species 0.000 description 2
• 241001489222 Saccharomycodes ludwigii Species 0.000 description 2
• 241000235004 Saccharomycopsis fibuligera Species 0.000 description 2
• 241001123650 Schwanniomyces occidentalis Species 0.000 description 2
• 241001123654 Schwanniomyces pseudopolymorphus Species 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 208000021386 Sjogren Syndrome Diseases 0.000 description 2
• 108091027967 Small hairpin RNA Proteins 0.000 description 2
• 241000521540 Starmera quercuum Species 0.000 description 2
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
• 206010057040 Temperature intolerance Diseases 0.000 description 2
• 102000005488 Thioesterase Human genes 0.000 description 2
• 102000036693 Thrombopoietin Human genes 0.000 description 2
• 108010041111 Thrombopoietin Proteins 0.000 description 2
• 241000235006 Torulaspora Species 0.000 description 2
• 241000229115 Torulaspora globosa Species 0.000 description 2
• 241001480015 Trigonopsis variabilis Species 0.000 description 2
• 241000223105 Trypanosoma brucei Species 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• 208000024780 Urticaria Diseases 0.000 description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 2
• 241000521542 Wickerhamomyces bovis Species 0.000 description 2
• 241001452678 Wickerhamomyces canadensis Species 0.000 description 2
• 101100029251 Zea mays PER2 gene Proteins 0.000 description 2
• 241000144010 Zygosaccharomyces mellis Species 0.000 description 2
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• GLEIMNFBCWCWPW-QOTBAUSGSA-N alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 GLEIMNFBCWCWPW-QOTBAUSGSA-N 0.000 description 2
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 2
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000002246 antineoplastic agent Substances 0.000 description 2
• 230000004596 appetite loss Effects 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 2
• 102000005936 beta-Galactosidase Human genes 0.000 description 2
• 102000006995 beta-Glucosidase Human genes 0.000 description 2
• 108010047754 beta-Glucosidase Proteins 0.000 description 2
• 108010055059 beta-Mannosidase Proteins 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000000711 cancerogenic effect Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 231100000315 carcinogenic Toxicity 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 230000016396 cytokine production Effects 0.000 description 2
• 229940127089 cytotoxic agent Drugs 0.000 description 2
• 230000006735 deficit Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000002988 disease modifying antirheumatic drug Substances 0.000 description 2
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
• 208000002173 dizziness Diseases 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 231100000655 enterotoxin Toxicity 0.000 description 2
• 231100000776 exotoxin Toxicity 0.000 description 2
• 239000002095 exotoxin Substances 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000006260 foam Substances 0.000 description 2
• 229930182830 galactose Natural products 0.000 description 2
• 150000004676 glycans Chemical class 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 229960002773 hyaluronidase Drugs 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 210000004969 inflammatory cell Anatomy 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical group 0.000 description 2
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 208000019017 loss of appetite Diseases 0.000 description 2
• 235000021266 loss of appetite Nutrition 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 208000005264 motor neuron disease Diseases 0.000 description 2
• 230000008693 nausea Effects 0.000 description 2
• 229940053128 nerve growth factor Drugs 0.000 description 2
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 150000002482 oligosaccharides Polymers 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 238000001050 pharmacotherapy Methods 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 229920001451 polypropylene glycol Polymers 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000003362 replicative effect Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 239000007320 rich medium Substances 0.000 description 2
• 238000011218 seed culture Methods 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 231100000617 superantigen Toxicity 0.000 description 2
• 230000009747 swallowing Effects 0.000 description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 108020002982 thioesterase Proteins 0.000 description 2
• 238000011200 topical administration Methods 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 239000002451 tumor necrosis factor inhibitor Substances 0.000 description 2
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 1
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
• 101150092249 ALG6 gene Proteins 0.000 description 1
• 208000002618 Aarskog syndrome Diseases 0.000 description 1
• 208000033745 Aarskog-Scott syndrome Diseases 0.000 description 1
• 208000004998 Abdominal Pain Diseases 0.000 description 1
• 201000007994 Aceruloplasminemia Diseases 0.000 description 1
• 206010000599 Acromegaly Diseases 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 208000005676 Adrenogenital syndrome Diseases 0.000 description 1
• 201000011452 Adrenoleukodystrophy Diseases 0.000 description 1
• 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 1
• 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 1
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
• 102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100031317 Alpha-N-acetylgalactosaminidase Human genes 0.000 description 1
• 208000029602 Alpha-N-acetylgalactosaminidase deficiency Diseases 0.000 description 1
• 208000031277 Amaurotic familial idiocy Diseases 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 206010002198 Anaphylactic reaction Diseases 0.000 description 1
• 208000028185 Angioedema Diseases 0.000 description 1
• 102100034613 Annexin A2 Human genes 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 206010003084 Areflexia Diseases 0.000 description 1
• 208000006820 Arthralgia Diseases 0.000 description 1
• 206010003402 Arthropod sting Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 206010068220 Aspartylglucosaminuria Diseases 0.000 description 1
• 241000134821 Aspergillus caesiellus Species 0.000 description 1
• 241000131314 Aspergillus candidus Species 0.000 description 1
• 241000131965 Aspergillus carneus Species 0.000 description 1
• 241000228193 Aspergillus clavatus Species 0.000 description 1
• 241000133597 Aspergillus deflectus Species 0.000 description 1
• 241000228197 Aspergillus flavus Species 0.000 description 1
• 241001225321 Aspergillus fumigatus Species 0.000 description 1
• 241000132177 Aspergillus glaucus Species 0.000 description 1
• 241000351920 Aspergillus nidulans Species 0.000 description 1
• 241000122824 Aspergillus ochraceus Species 0.000 description 1
• 240000006439 Aspergillus oryzae Species 0.000 description 1
• 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
• 241000228230 Aspergillus parasiticus Species 0.000 description 1
• 241000134912 Aspergillus penicillioides Species 0.000 description 1
• 241000228254 Aspergillus restrictus Species 0.000 description 1
• 241000131386 Aspergillus sojae Species 0.000 description 1
• 241000134719 Aspergillus tamarii Species 0.000 description 1
• 241001465318 Aspergillus terreus Species 0.000 description 1
• 241000122818 Aspergillus ustus Species 0.000 description 1
• 241000203233 Aspergillus versicolor Species 0.000 description 1
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 101150072950 BRCA1 gene Proteins 0.000 description 1
• FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 241000346770 Bispora Species 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 241001134740 Blastocrithidia Species 0.000 description 1
• 108010006654 Bleomycin Proteins 0.000 description 1
• 201000004569 Blindness Diseases 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 206010006220 Breast cyst Diseases 0.000 description 1
• 206010006272 Breast mass Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 206010006298 Breast pain Diseases 0.000 description 1
• 206010059027 Brugada syndrome Diseases 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
• 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
• 208000011380 COVID-19–associated multisystem inflammatory syndrome in children Diseases 0.000 description 1
• KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 241000847663 Candida ascalaphidarum Species 0.000 description 1
• 241000847665 Candida chauliodis Species 0.000 description 1
• 241000847666 Candida corydali Species 0.000 description 1
• 241000144583 Candida dubliniensis Species 0.000 description 1
• 241000736294 Candida ergatensis Species 0.000 description 1
• 241000192414 Candida insectamans Species 0.000 description 1
• 241000192312 Candida lyxosophila Species 0.000 description 1
• 241000222128 Candida maltosa Species 0.000 description 1
• 241000222173 Candida parapsilosis Species 0.000 description 1
• 241000192367 Candida quercitrusa Species 0.000 description 1
• 241000420434 Candida sinolaborantium Species 0.000 description 1
• 241000509448 Candida sojae Species 0.000 description 1
• 241000646536 Candida temnochilae Species 0.000 description 1
• 241000222178 Candida tropicalis Species 0.000 description 1
• 241000222157 Candida viswanathii Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 208000006029 Cardiomegaly Diseases 0.000 description 1
• 208000031229 Cardiomyopathies Diseases 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000283153 Cetacea Species 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 208000033810 Choroidal dystrophy Diseases 0.000 description 1
• 208000005595 Chronic Idiopathic Jaundice Diseases 0.000 description 1
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
• 208000031879 Chédiak-Higashi syndrome Diseases 0.000 description 1
• 208000003449 Classical Lissencephalies and Subcortical Band Heterotopias Diseases 0.000 description 1
• 241001508813 Clavispora lusitaniae Species 0.000 description 1
• 206010009691 Clubbing Diseases 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 206010010099 Combined immunodeficiency Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 206010010510 Congenital hypothyroidism Diseases 0.000 description 1
• 208000025103 Congenital isolated hyperinsulinism Diseases 0.000 description 1
• 208000016998 Conn syndrome Diseases 0.000 description 1
• 206010010774 Constipation Diseases 0.000 description 1
• 208000034656 Contusions Diseases 0.000 description 1
• 208000006069 Corneal Opacity Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000222716 Crithidia Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 208000014311 Cushing syndrome Diseases 0.000 description 1
• 241000223233 Cutaneotrichosporon cutaneum Species 0.000 description 1
• 241000235646 Cyberlindnera jadinii Species 0.000 description 1
• 241000878745 Cyberlindnera saturnus Species 0.000 description 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
• 206010011777 Cystinosis Diseases 0.000 description 1
• 230000007023 DNA restriction-modification system Effects 0.000 description 1
• 108010092160 Dactinomycin Proteins 0.000 description 1
• 208000011518 Danon disease Diseases 0.000 description 1
• 206010011878 Deafness Diseases 0.000 description 1
• 241000235035 Debaryomyces Species 0.000 description 1
• 206010012438 Dermatitis atopic Diseases 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 206010013700 Drug hypersensitivity Diseases 0.000 description 1
• 201000004943 Dubin-Johnson syndrome Diseases 0.000 description 1
• 102100039371 ER lumen protein-retaining receptor 1 Human genes 0.000 description 1
• 239000004129 EU approved improving agent Substances 0.000 description 1
• 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
• 206010014561 Emphysema Diseases 0.000 description 1
• 241000178951 Endomyces Species 0.000 description 1
• 241000224559 Endotrypanum Species 0.000 description 1
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 108010008165 Etanercept Proteins 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 206010016202 Familial Amyloidosis Diseases 0.000 description 1
• 108700000224 Familial apoceruloplasmin deficiency Proteins 0.000 description 1
• 208000001948 Farber Lipogranulomatosis Diseases 0.000 description 1
• 208000033149 Farber disease Diseases 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
• 208000004262 Food Hypersensitivity Diseases 0.000 description 1
• 108010058643 Fungal Proteins Proteins 0.000 description 1
• 101150038242 GAL10 gene Proteins 0.000 description 1
• 102100028496 Galactocerebrosidase Human genes 0.000 description 1
• 208000001287 Galactorrhea Diseases 0.000 description 1
• 206010017600 Galactorrhoea Diseases 0.000 description 1
• 208000017462 Galactosialidosis Diseases 0.000 description 1
• 108010042681 Galactosylceramidase Proteins 0.000 description 1
• 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
• 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
• 208000009796 Gangliosidoses Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 241000699694 Gerbillinae Species 0.000 description 1
• 208000007465 Giant cell arteritis Diseases 0.000 description 1
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 102400000321 Glucagon Human genes 0.000 description 1
• 108060003199 Glucagon Proteins 0.000 description 1
• 102000004547 Glucosylceramidase Human genes 0.000 description 1
• 108010017544 Glucosylceramidase Proteins 0.000 description 1
• 208000001500 Glycogen Storage Disease Type IIb Diseases 0.000 description 1
• 208000035148 Glycogen storage disease due to LAMP-2 deficiency Diseases 0.000 description 1
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 1
• 201000001885 Griscelli syndrome Diseases 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 101150009006 HIS3 gene Proteins 0.000 description 1
• 208000034507 Haematemesis Diseases 0.000 description 1
• 244000286779 Hansenula anomala Species 0.000 description 1
• 235000014683 Hansenula anomala Nutrition 0.000 description 1
• 206010019233 Headaches Diseases 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 206010019842 Hepatomegaly Diseases 0.000 description 1
• 206010019860 Hereditary angioedema Diseases 0.000 description 1
• 208000028572 Hereditary chronic pancreatitis Diseases 0.000 description 1
• 208000033981 Hereditary haemochromatosis Diseases 0.000 description 1
• 206010056976 Hereditary pancreatitis Diseases 0.000 description 1
• 241000224517 Herpetomonas Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102100024023 Histone PARylation factor 1 Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000972916 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Proteins 0.000 description 1
• 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 1
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
• 101000856395 Homo sapiens Cullin-9 Proteins 0.000 description 1
• 101000812437 Homo sapiens ER lumen protein-retaining receptor 1 Proteins 0.000 description 1
• 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 1
• 108090000144 Human Proteins Proteins 0.000 description 1
• 102000003839 Human Proteins Human genes 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 208000015178 Hurler syndrome Diseases 0.000 description 1
• 108700037017 Hyaluronidase Deficiency Proteins 0.000 description 1
• 208000005503 Hyaluronidase deficiency Diseases 0.000 description 1
• 208000008454 Hyperhidrosis Diseases 0.000 description 1
• 208000001021 Hyperlipoproteinemia Type I Diseases 0.000 description 1
• 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 206010020852 Hypertonia Diseases 0.000 description 1
• 206010051125 Hypofibrinogenaemia Diseases 0.000 description 1
• 206010021118 Hypotonia Diseases 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 208000001019 Inborn Errors Metabolism Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000003816 Interleukin-13 Human genes 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000000588 Interleukin-2 Human genes 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102100021592 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 102000000585 Interleukin-9 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 208000029523 Interstitial Lung disease Diseases 0.000 description 1
• 206010023126 Jaundice Diseases 0.000 description 1
• 206010023232 Joint swelling Diseases 0.000 description 1
• 208000003892 Kartagener syndrome Diseases 0.000 description 1
• 241000512931 Kazachstania humilis Species 0.000 description 1
• 206010023379 Ketoacidosis Diseases 0.000 description 1
• 208000007976 Ketosis Diseases 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 244000285963 Kluyveromyces fragilis Species 0.000 description 1
• 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
• 241000235650 Kluyveromyces marxianus Species 0.000 description 1
• 208000028226 Krabbe disease Diseases 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 101150021155 LIP2 gene Proteins 0.000 description 1
• 206010023804 Large intestine perforation Diseases 0.000 description 1
• 208000006302 Laron syndrome Diseases 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 206010024214 Lenticular opacities Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 241000222698 Leptomonas Species 0.000 description 1
• 201000009342 Limb-girdle muscular dystrophy Diseases 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 206010048911 Lissencephaly Diseases 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 208000007623 Lordosis Diseases 0.000 description 1
• 208000008930 Low Back Pain Diseases 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 1
• 206010025391 Macroglossia Diseases 0.000 description 1
• 208000035719 Maculopathy Diseases 0.000 description 1
• 208000027933 Mannosidase Deficiency disease Diseases 0.000 description 1
• 201000010991 Marinesco-Sjogren syndrome Diseases 0.000 description 1
• 208000006662 Mastodynia Diseases 0.000 description 1
• 108010038049 Mating Factor Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 208000036626 Mental retardation Diseases 0.000 description 1
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
• 241000937897 Meyerozyma caribbica Species 0.000 description 1
• 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
• 208000026940 Microvillus inclusion disease Diseases 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 201000004246 Miller-Dieker lissencephaly syndrome Diseases 0.000 description 1
• 208000035022 Miller-Dieker syndrome Diseases 0.000 description 1
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 1
• 229930192392 Mitomycin Natural products 0.000 description 1
• 208000003430 Mitral Valve Prolapse Diseases 0.000 description 1
• 208000034819 Mobility Limitation Diseases 0.000 description 1
• 208000000475 Mohr-Tranebjaerg syndrome Diseases 0.000 description 1
• 208000026072 Motor neurone disease Diseases 0.000 description 1
• 102000015728 Mucins Human genes 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 206010072928 Mucolipidosis type II Diseases 0.000 description 1
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 1
• 206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 1
• 208000025915 Mucopolysaccharidosis type 6 Diseases 0.000 description 1
• 208000003452 Multiple Hereditary Exostoses Diseases 0.000 description 1
• 208000000149 Multiple Sulfatase Deficiency Disease Diseases 0.000 description 1
• 208000035032 Multiple sulfatase deficiency Diseases 0.000 description 1
• 101000713102 Mus musculus C-C motif chemokine 1 Proteins 0.000 description 1
• 101000978374 Mus musculus C-C motif chemokine 12 Proteins 0.000 description 1
• 208000007101 Muscle Cramp Diseases 0.000 description 1
• 208000007379 Muscle Hypotonia Diseases 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 208000033833 Myelomonocytic Chronic Leukemia Diseases 0.000 description 1
• 102400000569 Myeloperoxidase Human genes 0.000 description 1
• 108090000235 Myeloperoxidases Proteins 0.000 description 1
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
• GVQYIMKPSDOTAH-UHFFFAOYSA-N NCC 1 Natural products CC1=C(C=C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(C2C=3NC(CC4=C(C(C)=C(C=O)N4)CCOC(=O)CC(O)=O)=C(C)C=3C(=O)C2C(O)=O)N1 GVQYIMKPSDOTAH-UHFFFAOYSA-N 0.000 description 1
• 241001123224 Naumovozyma dairenensis Species 0.000 description 1
• 101000652829 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) Exo-alpha-sialidase Proteins 0.000 description 1
• 206010065673 Nephritic syndrome Diseases 0.000 description 1
• 201000005118 Nephrogenic diabetes insipidus Diseases 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 208000003450 Neurogenic Diabetes Insipidus Diseases 0.000 description 1
• 208000008457 Neurologic Manifestations Diseases 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• 208000014060 Niemann-Pick disease Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 208000002366 Nut Hypersensitivity Diseases 0.000 description 1
• 208000035023 Oculocerebrorenal syndrome of Lowe Diseases 0.000 description 1
• 208000033716 Organic aciduria Diseases 0.000 description 1
• 206010031123 Orthopnoea Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 206010053869 POEMS syndrome Diseases 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241001504519 Papio ursinus Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 description 1
• 208000004843 Pendred Syndrome Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 1
• 102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 1
• 208000020547 Peroxisomal disease Diseases 0.000 description 1
• 241000224565 Phytomonas Species 0.000 description 1
• 241000235645 Pichia kudriavzevii Species 0.000 description 1
• 241000531871 Pichia terricola Species 0.000 description 1
• 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
• 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• HZEBHPIOVYHPMT-OUBTZVSYSA-N Polonium-210 Chemical compound [210Po] HZEBHPIOVYHPMT-OUBTZVSYSA-N 0.000 description 1
• 206010036030 Polyarthritis Diseases 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
• 206010036105 Polyneuropathy Diseases 0.000 description 1
• 208000016855 Porphyrin metabolism disease Diseases 0.000 description 1
• 208000004777 Primary Hyperoxaluria Diseases 0.000 description 1
• 206010036697 Primary hypothyroidism Diseases 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 201000005660 Protein C Deficiency Diseases 0.000 description 1
• 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
• 238000010240 RT-PCR analysis Methods 0.000 description 1
• 208000012322 Raynaud phenomenon Diseases 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 108010091086 Recombinases Proteins 0.000 description 1
• 102000018120 Recombinases Human genes 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 208000037656 Respiratory Sounds Diseases 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
• 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
• 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
• 241001489225 Saccharomycopsis capsularis Species 0.000 description 1
• 208000021811 Sandhoff disease Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000595478 Saturnispora saitoi Species 0.000 description 1
• 241000408466 Saturnus Species 0.000 description 1
• 241000192263 Scheffersomyces shehatae Species 0.000 description 1
• 241000235350 Schizosaccharomyces octosporus Species 0.000 description 1
• 101100539411 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uge1 gene Proteins 0.000 description 1
• 201000000552 Scott syndrome Diseases 0.000 description 1
• 206010039808 Secondary aldosteronism Diseases 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 206010040829 Skin discolouration Diseases 0.000 description 1
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
• 208000032140 Sleepiness Diseases 0.000 description 1
• 206010041349 Somnolence Diseases 0.000 description 1
• 208000005392 Spasm Diseases 0.000 description 1
• 102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 description 1
• 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 1
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
• 208000010112 Spinocerebellar Degenerations Diseases 0.000 description 1
• 206010041660 Splenomegaly Diseases 0.000 description 1
• 208000006045 Spondylarthropathies Diseases 0.000 description 1
• 206010072148 Stiff-Person syndrome Diseases 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• 208000001163 Tangier disease Diseases 0.000 description 1
• 208000022292 Tay-Sachs disease Diseases 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 206010044250 Toxic shock syndrome staphylococcal Diseases 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102100033598 Triosephosphate isomerase Human genes 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• 241001442399 Trypanosoma brucei gambiense Species 0.000 description 1
• 241001442397 Trypanosoma brucei rhodesiense Species 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 108700001567 Type I Schindler Disease Proteins 0.000 description 1
• 206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000014769 Usher Syndromes Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 206010046788 Uterine haemorrhage Diseases 0.000 description 1
• 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
• 206010047700 Vomiting Diseases 0.000 description 1
• 208000027276 Von Willebrand disease Diseases 0.000 description 1
• 241000382818 Wallaceina Species 0.000 description 1
• 206010047924 Wheezing Diseases 0.000 description 1
• 241000521600 Wickerhamomyces strasburgensis Species 0.000 description 1
• 208000006110 Wiskott-Aldrich syndrome Diseases 0.000 description 1
• 201000003412 Wolcott-Rallison syndrome Diseases 0.000 description 1
• 208000026589 Wolman disease Diseases 0.000 description 1
• 208000031970 X-linked Charcot-Marie-Tooth disease Diseases 0.000 description 1
• 208000010796 X-linked adrenoleukodystrophy Diseases 0.000 description 1
• 201000004525 Zellweger Syndrome Diseases 0.000 description 1
• 208000036813 Zellweger spectrum disease Diseases 0.000 description 1
• 241000420436 [Candida] amphicis Species 0.000 description 1
• 241000192429 [Candida] atlantica Species 0.000 description 1
• 241000192457 [Candida] atmosphaerica Species 0.000 description 1
• 241000847664 [Candida] blattae Species 0.000 description 1
• 241000142807 [Candida] carpophila Species 0.000 description 1
• 241000420432 [Candida] cerambycidarum Species 0.000 description 1
• 241000847667 [Candida] dosseyi Species 0.000 description 1
• 241000203998 [Candida] fructus Species 0.000 description 1
• 241000222126 [Candida] glabrata Species 0.000 description 1
• 241000191353 [Candida] haemulonis Species 0.000 description 1
• 241000192319 [Candida] insectorum Species 0.000 description 1
• 241000191335 [Candida] intermedia Species 0.000 description 1
• 241000192327 [Candida] membranifaciens Species 0.000 description 1
• 241000192351 [Candida] oleophila Species 0.000 description 1
• 241000203996 [Candida] oregonensis Species 0.000 description 1
• 241000192282 [Candida] tenuis Species 0.000 description 1
• 241000201773 [Candida] tsuchiyae Species 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 101150102866 adc1 gene Proteins 0.000 description 1
• 201000009628 adenosine deaminase deficiency Diseases 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
• 108010012864 alpha-Mannosidase Proteins 0.000 description 1
• 102000019199 alpha-Mannosidase Human genes 0.000 description 1
• 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 230000037354 amino acid metabolism Effects 0.000 description 1
• 235000011114 ammonium hydroxide Nutrition 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 230000036783 anaphylactic response Effects 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 201000009431 angiokeratoma Diseases 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 239000002518 antifoaming agent Substances 0.000 description 1
• 102000025171 antigen binding proteins Human genes 0.000 description 1
• 108091000831 antigen binding proteins Proteins 0.000 description 1
• 208000008784 apnea Diseases 0.000 description 1
• 229910052785 arsenic Inorganic materials 0.000 description 1
• RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229940091771 aspergillus fumigatus Drugs 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 201000008937 atopic dermatitis Diseases 0.000 description 1
• 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 1
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 229960001561 bleomycin Drugs 0.000 description 1
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
• 208000024330 bloating Diseases 0.000 description 1
• 210000001772 blood platelet Anatomy 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 229940127093 camptothecin Drugs 0.000 description 1
• VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• 208000032343 candida glabrata infection Diseases 0.000 description 1
• 229940055022 candida parapsilosis Drugs 0.000 description 1
• 230000023852 carbohydrate metabolic process Effects 0.000 description 1
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
• 229960004562 carboplatin Drugs 0.000 description 1
• 101150055766 cat gene Proteins 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000010307 cell transformation Effects 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 229960004630 chlorambucil Drugs 0.000 description 1
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 208000024042 cholesterol ester storage disease Diseases 0.000 description 1
• 208000013760 cholesteryl ester storage disease Diseases 0.000 description 1
• 208000017568 chondrodysplasia Diseases 0.000 description 1
• 208000003571 choroideremia Diseases 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 208000013116 chronic cough Diseases 0.000 description 1
• 201000010902 chronic myelomonocytic leukemia Diseases 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 235000019504 cigarettes Nutrition 0.000 description 1
• 230000001886 ciliary effect Effects 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
• 229960004316 cisplatin Drugs 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000003184 complementary RNA Substances 0.000 description 1
• 108700036934 congenital Sucrase-isomaltase deficiency Proteins 0.000 description 1
• 208000001970 congenital sucrase-isomaltase deficiency Diseases 0.000 description 1
• 208000018631 connective tissue disease Diseases 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 239000003246 corticosteroid Substances 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 239000002577 cryoprotective agent Substances 0.000 description 1
• 229960004397 cyclophosphamide Drugs 0.000 description 1
• 229960000640 dactinomycin Drugs 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
• 229960000975 daunorubicin Drugs 0.000 description 1
• 201000008696 deafness-dystonia-optic neuronopathy syndrome Diseases 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 201000001981 dermatomyositis Diseases 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000003795 desorption Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
• 150000002031 dolichols Chemical class 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 238000011143 downstream manufacturing Methods 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 230000007937 eating Effects 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
• 229960000403 etanercept Drugs 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
• 229960005420 etoposide Drugs 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 201000001386 familial hypercholesterolemia Diseases 0.000 description 1
• 208000019298 familial intrahepatic cholestasis Diseases 0.000 description 1
• 201000011110 familial lipoprotein lipase deficiency Diseases 0.000 description 1
• 208000015700 familial long QT syndrome Diseases 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 230000035558 fertility Effects 0.000 description 1
• 210000004905 finger nail Anatomy 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 229960002949 fluorouracil Drugs 0.000 description 1
• 235000020932 food allergy Nutrition 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 201000008049 fucosidosis Diseases 0.000 description 1
• 201000006440 gangliosidosis Diseases 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 208000029281 geleophysic dysplasia Diseases 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 230000009395 genetic defect Effects 0.000 description 1
• 238000011331 genomic analysis Methods 0.000 description 1
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
• 229960004666 glucagon Drugs 0.000 description 1
• 229960002442 glucosamine Drugs 0.000 description 1
• 201000004502 glycogen storage disease II Diseases 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 231100000869 headache Toxicity 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000010370 hearing loss Effects 0.000 description 1
• 231100000888 hearing loss Toxicity 0.000 description 1
• 208000016354 hearing loss disease Diseases 0.000 description 1
• 208000035861 hematochezia Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 231100000753 hepatic injury Toxicity 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000009601 hereditary spherocytosis Diseases 0.000 description 1
• 208000013746 hereditary thrombophilia due to congenital protein C deficiency Diseases 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 108010045961 human beta1,4-galactosyltransferase Proteins 0.000 description 1
• 102000005383 human beta1,4-galactosyltransferase Human genes 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 229960001101 ifosfamide Drugs 0.000 description 1
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 239000000367 immunologic factor Substances 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000002637 immunotoxin Effects 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 231100000608 immunotoxin Toxicity 0.000 description 1
• 229940051026 immunotoxin Drugs 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 208000016245 inborn errors of metabolism Diseases 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 208000017482 infantile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 229960000598 infliximab Drugs 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 208000015978 inherited metabolic disease Diseases 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 206010022437 insomnia Diseases 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229960001388 interferon-beta Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 230000005865 ionizing radiation Effects 0.000 description 1
• 230000005722 itchiness Effects 0.000 description 1
• 230000008407 joint function Effects 0.000 description 1
• 208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 208000014817 lissencephaly spectrum disease Diseases 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 108010045758 lysosomal proteins Proteins 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 108010005335 mannoproteins Proteins 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 208000008585 mastocytosis Diseases 0.000 description 1
• SKEFKEOTNIPLCQ-LWIQTABASA-N mating hormone Chemical compound C([C@@H](C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCS(C)=O)C(=O)NC(CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CN=CN1 SKEFKEOTNIPLCQ-LWIQTABASA-N 0.000 description 1
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 229960004961 mechlorethamine Drugs 0.000 description 1
• HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
• 210000001006 meconium Anatomy 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 229960001924 melphalan Drugs 0.000 description 1
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 239000007003 mineral medium Substances 0.000 description 1
• 230000004898 mitochondrial function Effects 0.000 description 1
• 230000006677 mitochondrial metabolism Effects 0.000 description 1
• 230000002297 mitogenic effect Effects 0.000 description 1
• 229960004857 mitomycin Drugs 0.000 description 1
• 208000005907 mitral valve insufficiency Diseases 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 230000000921 morphogenic effect Effects 0.000 description 1
• 229940051875 mucins Drugs 0.000 description 1
• 201000007769 mucolipidosis Diseases 0.000 description 1
• 208000020460 mucolipidosis II alpha/beta Diseases 0.000 description 1
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
• 208000011045 mucopolysaccharidosis type 3 Diseases 0.000 description 1
• 208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 1
• 208000015325 multicentric Castleman disease Diseases 0.000 description 1
• 201000000585 muscular atrophy Diseases 0.000 description 1
• 231100000219 mutagenic Toxicity 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 201000005119 neurohypophyseal diabetes insipidus Diseases 0.000 description 1
• 201000007642 neuronal ceroid lipofuscinosis 1 Diseases 0.000 description 1
• 201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 231100000956 nontoxicity Toxicity 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 201000010854 nut allergy Diseases 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 201000006352 oculocerebrorenal syndrome Diseases 0.000 description 1
• 201000007909 oculocutaneous albinism Diseases 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 201000008152 organic acidemia Diseases 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 208000012144 orthopnea Diseases 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• 229940124583 pain medication Drugs 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000003200 peritoneal cavity Anatomy 0.000 description 1
• 206010034674 peritonitis Diseases 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000002319 photoionisation mass spectrometry Methods 0.000 description 1
• 238000000554 physical therapy Methods 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
• 229960001237 podophyllotoxin Drugs 0.000 description 1
• YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 208000030428 polyarticular arthritis Diseases 0.000 description 1
• 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 208000005987 polymyositis Diseases 0.000 description 1
• 230000007824 polyneuropathy Effects 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 208000013846 primary aldosteronism Diseases 0.000 description 1
• 201000009266 primary ciliary dyskinesia Diseases 0.000 description 1
• 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
• 229960000624 procarbazine Drugs 0.000 description 1
• CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
• 238000004886 process control Methods 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 208000005631 pseudoachondroplasia Diseases 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 230000004144 purine metabolism Effects 0.000 description 1
• 201000010108 pycnodysostosis Diseases 0.000 description 1
• 230000004147 pyrimidine metabolism Effects 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000003156 radioimmunoprecipitation Methods 0.000 description 1
• 229910052704 radon Inorganic materials 0.000 description 1
• SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 108700012830 rat Lip2 Proteins 0.000 description 1
• 238000006268 reductive amination reaction Methods 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 206010039722 scoliosis Diseases 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 208000013220 shortness of breath Diseases 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 208000027128 sialidosis type 1 Diseases 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 230000037370 skin discoloration Effects 0.000 description 1
• 231100000046 skin rash Toxicity 0.000 description 1
• 201000002859 sleep apnea Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000000779 smoke Substances 0.000 description 1
• 206010041232 sneezing Diseases 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 201000005671 spondyloarthropathy Diseases 0.000 description 1
• 201000006831 spondyloepiphyseal dysplasia tarda Diseases 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 230000037359 steroid metabolism Effects 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 238000000756 surface-enhanced laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229960001603 tamoxifen Drugs 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• 206010043207 temporal arteritis Diseases 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 238000012956 testing procedure Methods 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
• 210000004906 toe nail Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 239000012096 transfection reagent Substances 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 208000009999 tuberous sclerosis Diseases 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 1
• 229960003048 vinblastine Drugs 0.000 description 1
• 229960004528 vincristine Drugs 0.000 description 1
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
• 230000004393 visual impairment Effects 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 230000008673 vomiting Effects 0.000 description 1
• 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
• 230000003313 weakening effect Effects 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1
• 208000016261 weight loss Diseases 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1